Ciencia, neoliberalismo y bioeconomía
DOI:
https://doi.org/10.52712/issn.1850-0013-687Palavras-chave:
bioeconomía, biotecnología, neoliberalismo, mercado, cienciaResumo
La bioeconomía es un proyecto y al mismo tiempo una visión situada dentro de la narrativa neoliberal del crecimiento económico y de la competitividad y habla de una nueva economía basada en la manipulación, explotación y apropiación tecnológica de la materia viviente. Este artículo intenta dibujar un mapa del imaginario y de los objetivos de la bioeconomía a través del análisis de los discursos elaborados (y que circulan) por la UE y la OCDE. Más específicamente, explora la relación entre la bioeconomía como narrativa, con sus estrategias de políticas públicas, y el sistema filosófico neoliberal que la inspira. La bioeconomía aparece como un paso más allá de la misma economía del conocimiento en el proceso neoliberal dispuesto a extender ética y practica del mercado a espacios sociales y biológicos antes regulados por otros principios. Mirando a la reproducción asistida y al bio-pharming, intenta sacar a la luz el papel de las biotecnologías en la constitución, institucionalización y regulación de la bioeconomía. En la conclusión, se vislumbran algunas de las implicaciones políticas y sociales de la transición a un sistema económico basado en la bioeconomía, sobre todo con relación al proceso de de-politicización y de restricción de acceso a la naturaleza que las bioeconomías necesitan para consolidarse.
Downloads
Referências
BARRY, A. y SLATER, D. (2002): “Introduction: the technological economy”, Economy and society,31, pp. 175-193.
BIRCH, K. (2006): “The neoliberal underpinnings of the bioeconomy: the ideological discourses and practices of economic competitiveness”, Genomics, Society and Policy,2, pp. 1-15.
BIRCH, K. (2007): “The virtual bioeconomy: the’failure’of performativity and the implications for bioeconomics”, Distinktion: Scandinavian Journal of Social Theory,14, pp. 83-99.
BIRCH, K., LEVIDOW, L. y PAPAIOANNOU, T. (2010): “Sustainable capital? The neoliberalization of nature and knowledge in the European ‘knowledge-based bio- economy’”, Sustainability,2, pp. 2898-2918.
BROCKINGTON, D. e IGOE, J. (2007): Neoliberal Conservation: ABrief Introduction.
CHILVERS, J. y BURGESS, J. (2008): “Power relations: the politics of risk and procedure in nuclear waste governance”, Environment and Planning A, 40, pp. 1881-1900.
COOPER, M. (2008): Life as surplus: Biotechnology and capitalism in the neoliberal era,University of Washington Pr.
EU COMMISSION (2002): Life Sciences and Biotechnology-a Strategy for Europe: Communication from the Commission to the European Parliament, the Council, the Economic and Social Committee and the Committee of the Regions,Office for Official Publications of the European Communities.
EU COMMISSION (2004): Towards a European knowledge-based bioeconomy, Luxemburgo, Office for Official Publications of the European Communities.
EU COMMISSION (2007): En route to the Knowledge-based Bio-economy,Bruselas, European Commission, 1-23l.
EU COMMISSION (2010): The Knowledge-based bio-economy (KBBE) in Europe: achievements and challenges, Bruselas, Flemish Government 1-68l.
GLEICHER, N., WEGHOFER, A. y BARAD, D. (2006): “A formal comparison of the practice of assisted reproductive technologies between Europe and the USA”, Human Reproduction,21, pp. 1945-1950.
HEDGECOE, A. (2004): The politics of personalised medicine: pharmacogenetics in the clinic,Cambridge University Pr.
HEDGECOE, A. y MARTIN, P. (2003): “The Drugs Don’t Work”, Social Studies of Science,33, pp. 327-364.
HOPKINS, M. M., MARTIN, P. A., NIGHTINGALE, P., KRAFT, A. y MAHDI, S. (2007): “The myth of the biotech revolution: An assessment of technological, clinical and organisational change”, Research Policy,36, pp. 566-589.
IN, A. I. S. P. P. (2001): Fostering the Bioeconomic Revolution.
JASANOFF, S. (2004): States of knowledge: the co-production of science and social order, Psychology Press.
MACNAGHTEN, P., KEARNES, M. B. y WYNNE, B. (2005): “Nanotechnology, governance, and public deliberation: what role for the social sciences?”, Science communication,27, p. 268.
MEADOWS, D. H., MEADOWS, D. L., RANDERS, J., BEHRENS, W. W. y OF, R. C. (1972): The limits to growth,Universe books New York.
MIROWSKI, P. (1994): “A Visible Hand in the Marketplace of Ideas: Precision Measurement as Arbitage”, Science in Context,7, pp. 563-589.
MIROWSKI, P. (2011): Science-mart: privatizing American science,Harvard University Press.
MIROWSKI, P. y PLEHWE, D. (2009): The road from Mont Pèlerin: the making of the neoliberal thought collective, Harvard Univ Press.
MITCHELL, R. y WALDBY, C. (2010): “National Biobanks: clinical labor, risk production, and the creation of biovalue”, Science, Technology & Human Values,35, p. 330.
NOVAS, C. (2006): “The political economy of hope: patients’ organizations, science and biovalue”, BioSocieties,1, p. 289.
OCDE (2006): Scoping document: The bioeconomy to 2030: Designing a policy agenda, París, OCDE, 382-286l.
OCDE (2009): The Bioeconomy to 2030: Designing a policy agenda,París, OCDE, 1- 18l.
PAVONE, V. y ARIAS, F. (2011): “Beyond the Geneticization Thesis: The Political Economy of PGD/PGS in Spain”, Science, Technology & Human Values.
SHEEHAN, P. y TEGART, G. (1998): Working for the future: technology and employment in the global knowledge economy,Victoria University Press for the Centre for Strategic Economic Studies.
WALDBY, C. (2002): “Stem cells, tissue cultures and the production of biovalue”, Health,6, p. 305.
WALDBY, C. y COOPER, M. (2010): “From reproductive work to regenerative labour”, Feminist Theory,11, pp. 3-22.
WALDBY, C. y MITCHELL, R. (2006): Tissue economies: Blood, organs, and cell lines in late capitalism,Duke University Press Books.
WRIGHT, V. C., CHANG, J., JENG, G., MACALUSO, M. y CENTERS FOR DISEASE CONTROL & PREVENTION (2008): “Assisted reproductive technology surveillance - United States, 2005”, MMWR. Surveillance summaries: Morbidity and mortality weekly report. Surveillance summaries / CDC,57, pp. 1-23.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 CC Attribution 4.0
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Todas os números de CTS e seus artigos individuais estão sob uma licença CC-BY.
Desde 2007, a CTS proporciona acesso livre, aberto e gratuito a todos seus conteúdos, incluídos o arquivo completo da edição quadrimestral e os diversos produtos apresentados na plataforma eletrônica. Esta decisão é baseada no entendimento de que fornecer acesso livre aos materiais publicados ajuda a ter uma maior e melhor troca de conhecimentos.
Por sua vez, em se tratando da edição quadrimestral, a revista permite aos repositórios institucionais e temáticos, bem como aos sites pessoais, o autoarquivo dos artigos na versão post-print ou versão editorial, logo após da publicação da versão definitiva de cada número e sob a condição de incorporar ao autoarquivo um link direcionado à fonte original.
